Abstract
Antidepressants are among the most-prescribed drugs worldwide, and selective serotonin reuptake inhibitors (SSRIs) are among the most prescribed antidepressants, most commonly used for major depression. We sought to increase our understanding of the biological relationships between SSRI use and a range of psychiatric traits by conducting Genome Wide Association Study (GWAS) in two large datasets, the UK Biobank (UKB) and the US Million Veteran Program (MVP). We conducted GWAS across 22 autosomes and the X chromosome in 777,952 individuals of European ancestry (191,800 SSRI users, 586,152 controls) and 112,526 individuals of African ancestry (53,499 SSRI users, 59,027 controls). We identified 40 genome-wide significant (GWS) loci, including two on the X chromosome. Using linkage disequilibrium score regression we detected strong correlations between MVP and the independent UKB cohort with use of specific SSRIs (fluoxetine genetic correlation (rg)=0.82 and citalopram rg=0.89) as well as with headaches (rg=0.80), major depressive disorder (MDD; rg=0.77), and spondylosis (rg=0.84), suggesting stability in the trait definition across cohorts. To evaluate differences between the genomic variance captured by the SSRI-use trait vs. MDD, we performed a comparative rg analysis between MDD and the meta-analysis for SSRI exposure and found significant differences, most notably for educational attainment (SSRI rg = -0.38 , MDD rg= -0.26), cognitive performance (SSRI rg = -0.31, MDD rg=-0.15), and depression (SSRI rg = 0.80, MDD rg= 0.97). We compared locus discovery for SSRI use and MDD in the MVP, and found greater discovery for SSRI use (28 vs 17 risk loci). SSRI use is likely in part a proxy trait for MDD, while also presenting differences that may prove useful to disentangle MDD from other traits (e.g., anxiety disorders) that use similar pharmacological treatment.
Competing Interest Statement
J.G. is paid for editorial work on the journal Complex Psychiatry. M.B.S. has stock options in Oxeia Biopharmaceuticals and EpiVario. He has been paid for his editorial work on Depression and Anxiety (Editor-in-Chief), Biological Psychiatry (Deputy Editor) and UpToDate (Co-Editor-in-Chief for Psychiatry). No other authors report competing interests.
Funding Statement
This research is based on data from the Million Veteran Program, Office of Research and Development, Veterans Health Administration, and was supported by MVP092 and MVP069 as well as award #2IO1BX006482 and #5IK2BX005058.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research involving MVP ss approved by the Veterans Affairs Central IRB; the current project was also approved by IRBs in the Veterans Affairs Connecticut Healthcare System.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.